Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (15)

2011

  1. Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non-Small-Cell Lung Cancer Patients with EGFR Mutations

    Clinical Cancer Research, Vol. 17, Núm. 5, pp. 1160-1168

2010

  1. Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

    Journal of Translational Medicine, Vol. 8

  2. Valor pronóstico de la concentración del inhibidor de la fibrinolisis activable por trombina y del polimorfismo C1040T en el infarto agudo de miocardio tratado con fibrinolisis

    Medicina Intensiva, Vol. 34, Núm. 8, pp. 513-522

2009

  1. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): Prognostic impact and potential role as markers of occult micrometastases

    Annals of Oncology, Vol. 20, Núm. 1, pp. 91-97

  2. Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma

    Breast Cancer Research and Treatment, Vol. 117, Núm. 2, pp. 433-441

  3. Utility of p16 immunohistochemistry for the identification of Lynch syndrome

    Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162

2008

  1. Association between the Thr325Ile and Ala147Thr polymorphisms of the TAFI gene and the risk of venous thromboembolic disease

    Clinical and Applied Thrombosis/Hemostasis

2007

  1. Intragenomic 16s rDNA divergence in Haloarcula marismortui is an adaptation to different temperatures

    Journal of Molecular Evolution, Vol. 65, Núm. 6, pp. 687-696

2006

  1. Cell-free DNA concentration in pleural fluid and serum: Quantitative approach and potential prognostic factor in patients with cancer and pleural effusions

    Clinical Lung Cancer, Vol. 8, Núm. 2, pp. 140-145

  2. Detection of BRAF V600E mutation in colorectal cancer: Comparison of automatic sequencing and real-time chemistry methodology

    Journal of Molecular Diagnostics, Vol. 8, Núm. 5, pp. 540-543

  3. The detection of bacterial DNA in blood of rats with CCl 4-induced cirrhosis with ascites represents episodes of bacterial translocation

    Hepatology, Vol. 44, Núm. 3, pp. 633-639

  4. Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD) [2]

    Thrombosis and Haemostasis

2005

  1. Detection and identification of bacterial DNA in serum from patients with acute pancreatitis

    Gut, Vol. 54, Núm. 9, pp. 1293-1297

2004

  1. A Sequential Study of Serum Bacterial DNA in Patients with Advanced Cirrhosis and Ascites

    Hepatology, Vol. 39, Núm. 2, pp. 484-491

  2. Control of heterotrophic prokaryotic abundance and growth rate in hypersaline planktonic environments

    Aquatic Microbial Ecology, Vol. 34, Núm. 2, pp. 193-206